BlackRock Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $8K | Hold |
67
| – | – | ﹤0.01% | 3516 |
|
|
2016
Q3 | $10K | Hold |
67
| – | – | ﹤0.01% | 3503 |
|
|
2016
Q2 | $8K | Hold |
67
| – | – | ﹤0.01% | 3553 |
|
|
2016
Q1 | $8K | Hold |
67
| – | – | ﹤0.01% | 3543 |
|
|
2015
Q4 | $13K | Hold |
67
| – | – | ﹤0.01% | 3519 |
|
|
2015
Q3 | $11K | Buy |
67
+28
| +72% | +$4.6K | ﹤0.01% | 3588 |
|
|
2015
Q2 | $25K | Sell |
39
-118
| -75% | -$75.6K | ﹤0.01% | 3407 |
|
|
2015
Q1 | $81K | Buy |
157
+41
| +35% | +$21.2K | ﹤0.01% | 3097 |
|
|
2014
Q4 | $62K | Sell |
116
-305
| -72% | -$163K | ﹤0.01% | 3193 |
|
|
2014
Q3 | $631K | Sell |
421
-694
| -62% | -$1.04M | ﹤0.01% | 1752 |
|
|
2014
Q2 | $1.53M | Sell |
1,115
-516
| -32% | -$707K | ﹤0.01% | 1230 |
|
|
2014
Q1 | $2.26M | Sell |
1,631
-4,890
| -75% | -$6.79M | ﹤0.01% | 1131 |
|
|
2013
Q4 | $6.49M | Sell |
6,521
-354
| -5% | -$352K | 0.01% | 914 |
|
|
2013
Q3 | $7.16M | Sell |
6,875
-562
| -8% | -$585K | 0.01% | 874 |
|
|
2013
Q2 | $8.1M | Buy |
+7,437
| New | +$8.1M | 0.01% | 831 |
|